Advanced Search

column
Inaugural Editorial: New Era, New Journal
Jia FAN
2022, 1(1): 1-2. DOI: 10.11910/j.issn.2791-3937.2022.20220004
Abstract FullText HTML PDF
Prevalence and Clinical Implication of t(11;14) in Light-Chain Amyloidosis with or without Coexistent Multiple Myeloma in the Era of Proteasome Inhibitors
Tianhong XU, Zheng WEI, Jing LI, Jiadai XU, Yang YANG, Wenjing WANG, Jingli ZHUANG, Zhimei WANG, Lili JI, Luya CHENG, Weiguang WANG, Zhixiang CHENG, Yang KE, Ling YUAN, Peng LIU
2022, 1(1): 3-10. DOI: 10.11910/j.issn.2791-3937.2022.20220001
Abstract FullText HTML PDF
RAS Signaling Targeted Cancer Therapy
Zhuoran QI, Xiaojing DU, Quanlin AN, Jinglin XIA, Xin CAO
2022, 1(1): 11-23. DOI: 10.11910/j.issn.2791-3937.2022.20210001
Abstract FullText HTML PDF
Brain Metastasis of Non-small-cell Lung Cancer
Tao JIANG, Shengxiang REN, Caicun ZHOU
2022, 1(1): 24-31. DOI: 10.11910/j.issn.2791-3937.2022.20220002
Abstract FullText HTML PDF
Research progress of circular RNAs in drug resistance of liver cancer
Zhifan ZUO, Tao HAN
2022, 1(1): 32-38. DOI: 10.11910/j.issn.2791-3937.2022.20210002
Abstract FullText HTML PDF
Artificial Intelligence in Neuro-oncology: Friend or Foe of Neurosurgeons?
Zhenyu GONG, Maximilian SCHWENDNER, Tao XU
2022, 1(1): 39-46. DOI: 10.11910/j.issn.2791-3937.2022.20210003
Abstract FullText HTML PDF
Why a P value <0.05 does not necessarily mean statistical significance: controversy over overall survival results of the ORIENT-11 trial
Fei LIANG
2022, 1(1): 47-48. DOI: 10.11910/j.issn.2791-3937.2022.20220003
Abstract FullText HTML PDF

Supported by: Beijing Renhe Information Technology Co., Ltd.